Human miR-1228 as a stable endogenous control for the quantification of circulating microRNAs in cancer patients

International Journal of Cancer

Volumn 135, Issue 5, 2014, Pages 1187-1194

  Hu, Jie ^a   Wang, Zheng ^a   Liao, Bo Yi ^a   Yu, Lei ^a   Gao, Xue ^b   Lu, Shaohua ^a   Wang, Shuyang ^a   Dai, Zhi ^a   Zhang, Xin ^a   Chen, Qing ^a   Qiu, Shuang Jian ^a   Wu, Ying ^a   Zhu, Hongguang ^a,b   Fan, Jia ^a   Zhou, Jian ^a   Wang, Jiping ^c  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

cancer; circulating microRNA; endogenous control; normalization; qRT PCR

Indexed keywords

MICRORNA; MICRORNA 1225 3P; MICRORNA 1228; MICRORNA 134; MICRORNA 16; MICRORNA 188 5P; MICRORNA 223; MICRORNA 30D; MICRORNA 939; MICRORNA 940; PROTEIN LET 7A; PROTEIN RNU6B; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ANALYTIC METHOD; ARTICLE; BREAST CANCER; CANCER PATIENT; COLORECTAL CANCER; CONTROLLED STUDY; ESOPHAGUS CANCER; FEMALE; HOUSEKEEPING GENE; HUMAN; INGENUITY PATHWAY ANALYSIS; KIDNEY CANCER; LIVER CELL CARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STOMACH CANCER; VALIDATION PROCESS;

CANCER; CIRCULATING MICRORNA; ENDOGENOUS CONTROL; NORMALIZATION; QRT-PCR;

ADULT; COHORT STUDIES; CONTROL GROUPS; FEMALE; GENE EXPRESSION PROFILING; GENES, ESSENTIAL; HEPATITIS B, CHRONIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84902544989     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28757     Document Type: Article

References (34)

1. Esquela-Kerscher A, Slack FJ,. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-69.
2. Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105: 10513-18.
3. Barad O, Meiri E, Avniel A, et al. MicroRNA expression detected by oligonucleotide microarrays: system establishment and expression profiling in human tissues. Genome Res 2004; 14: 2486-94.
4. Mestdagh P, Feys T, Bernard N, et al. High-throughput stem-loop RT-qPCR miRNA expression profiling using minute amounts of input RNA. Nucleic Acids Res 2008; 36: e143.
5. Thellin O, Zorzi W, Lakaye B, et al. Housekeeping genes as internal standards: use and limits. J Biotechnol 1999; 75: 291-5.
6. Davoren PA, McNeill RE, Lowery AJ, et al. Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer. BMC Mol Biol 2008; 9: 76.
7. Chang KH, Mestdagh P, Vandesompele J, et al. MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer. BMC Cancer 2010; 10: 173.
8. Liang Y, Ridzon D, Wong L, et al. Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 2007; 8: 166.
9. Schaefer A, Jung M, Miller K, et al. Suitable reference genes for relative quantification of miRNA expression in prostate cancer. Exp Mol Med 2010; 42: 749-58.
10. Bargaje R, Hariharan M, Scaria V, et al. Consensus miRNA expression profiles derived from interplatform normalization of microarray data. RNA 2010; 16: 16-25.
11. Song J, Bai Z, Han W, et al. Identification of suitable reference genes for qPCR analysis of serum microRNA in gastric cancer patients. Dig Dis Sci 2011; 57: 897-904.
12. Zuo Z, Calin GA, de Paula HM, et al. Circulating microRNAs let-7a and miR-16 predict progression-free survival and overall survival in patients with myelodysplastic syndrome. Blood 2011; 118: 413-15.
13. Navarro A, Diaz T, Gallardo E, et al. Prognostic implications of miR-16 expression levels in resected non-small-cell lung cancer. J Surg Oncol 2011; 103: 411-15.
14. Iorio MV, Ferracin M, Liu C-G, et al. MicroRNA Gene Expression Deregulation in Human Breast Cancer. Cancer Res 2005; 65: 7065-70.
15. Kurashige J, Watanabe M, Iwatsuki M, et al. Overexpression of microRNA-223 regulates the ubiquitin ligase FBXW7 in oesophageal squamous cell carcinoma. Br J Cancer 2012; 106: 182-8.
16. Li J, Guo Y, Liang X, et al. MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4. J Cancer Res Clin Oncol 2012; 138: 763-74.
17. Xu F, Zhang X, Lei Y, et al. Loss of repression of HuR translation by miR-16 may be responsible for the elevation of HuR in human breast carcinoma. J Cell Biochem 2010; 111: 727-34.
18. Zhou J, Yu L, Gao X, et al. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J Clin Oncol 2011; 29: 4781-8.
19. Andersen CL, Jensen JL, Orntoft TF,. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 2004; 64: 5245-50.
20. Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3: RESEARCH0034.
21. Hurley J, Roberts D, Bond A, et al. Stem-loop RT-qPCR for microRNA expression profiling. Methods Mol Biol 2012; 822: 33-52.
22. Kroh EM, Parkin RK, Mitchell PS, et al. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 2010; 50: 298-301.
23. Chen ZH, Zhang GL, Li HR, et al. A panel of five circulating microRNAs as potential biomarkers for prostate cancer. Prostate 2012; 72: 1443-52.
24. Zhao H, Shen J, Medico L, et al. A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS One 2010; 5: e13735.
25. Heneghan HM, Miller N, Lowery AJ, et al. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg 2010; 251: 499-505.
26. Roth C, Rack B, Muller V, et al. Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer. Breast Cancer Res 2010; 12: R90.
27. Zhu HT, Dong QZ, Wang G, et al. Identification of suitable reference genes for qRT-PCR analysis of circulating microRNAs in hepatitis B virus-infected patients. Mol Biotechnol 2012; 50: 49-56.
28. Lee JY, Kim HJ, Yoon NA, et al. Tumor suppressor p53 plays a key role in induction of both tristetraprolin and let-7 in human cancer cells. Nucleic Acids Res 2013; 41: 5614-25.
29. Zhang ZZ, Liu X, Wang DQ, et al. Hepatitis B virus and hepatocellular carcinoma at the miRNA level. World J Gastroenterol 2011; 17: 3353-8.
30. Ji J, Shi J, Budhu A, et al. MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med 2009; 361: 1437-47.
31. Zhu Y, Lu Y, Zhang Q, et al. MicroRNA-26a/b and their host genes cooperate to inhibit the G1/S transition by activating the pRb protein. Nucleic Acids Res 2012; 40: 4615-25.
32. Yan B, Zhao JL,. miR-1228 prevents cellular apoptosis through targeting of MOAP1 protein. Apoptosis 2012; 17: 717-24.
33. Borgan E, Navon R, Vollan HK, et al. Ischemia caused by time to freezing induces systematic microRNA and mRNA responses in cancer tissue. Mol Oncol 2011; 5: 564-76.
34. Wang S, Xiang J, Li Z, et al. A plasma microRNA panel for early detection of colorectal cancer. Int J Cancer, 2013. doi: 10.1002/ijc.28136.